April 25, 2019
As part of the Lundbeck Foundation’s new award strategy, we are launching a programme with the aim of encouraging scientists to apply for funding for their most audacious ideas. Lundbeck Foundation’s new grant programme, LF Experiment, focuses on funding the most extraordinary and ambitious research projects, and we are now accepting applications. If you hold...
Lund, Sweden, 08.00 am CET, 25 April 2019 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids will publish its Q1 2019 Interim Report on Wednesday 2 May 2019 at 08.00 am CET. The Company will hold a conference call and an online presentation on the same day at 10.00 am...
Cambridge, UK and Indianapolis, US – 25 April 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) announces that additional data and analyses from its positive Phase 3 clinical trial of BARHEMSYS® (intravenous amisulpride) as a rescue treatment of established post-operative nausea & vomiting (PONV) will be presented today in a poster at...


The Lundbeck Foundation seeks greater diversity among grant recipients and prizewinners
1. May 2019
Deep dive in the deadly chemistry of snakebites
26. April 2019
Brain’s ‘sea horse’ to ensure better treatment of mental disorders
9. April 2019


Lundbeckfonden Ventures

Lundbeckfonden Emerge